Authors:
Lee, MH
Kim, HJ
Kim, SH
Kim, SO
Lee, DH
Lim, H
Yoo, SE
Lee, MG
Citation: Mh. Lee et al., High-performance liquid chromatographic analysis of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378, RES COM M P, 109(3-4), 2001, pp. 249-256
Citation: Yd. Gong et Se. Yoo, Solid-phase synthesis of benzopyran derivatives via highly efficient epoxidation using two-phase solvents, B KOR CHEM, 22(9), 2001, pp. 941-942
Authors:
Zheng, W
Ji, H
Szabo, Z
Brown, PR
Yoo, SE
Sandberg, K
Citation: W. Zheng et al., Coordinate regulation of canine glomeruli and adrenal angiotensin receptors by dietary sodium manipulation, KIDNEY INT, 59(5), 2001, pp. 1881-1890
Authors:
Park, SH
Choi, SU
Lee, CO
Yoo, SE
Yoon, SK
Kim, YK
Ryu, SY
Citation: Sh. Park et al., Costunolide, a sesquiterpene from the stem bark of Magnolia sieboldii, inhibits the RAS-farnesyl-proteintransferase, PLANTA MED, 67(4), 2001, pp. 358-359
Citation: Se. Yoo et al., The conformation and activity relationship of benzofuran type of angiotensin II receptor antagonists, BIO MED CH, 8(9), 2000, pp. 2311-2316
Authors:
Lee, BH
Shin, HS
Lee, CO
Park, SH
Yoo, SE
Yi, KY
Jung, NP
Choi, SU
Citation: Bh. Lee et al., Effects of KR-30035, a novel multidrug-resistance modulator, on the cardiovascular system of rats in vivo and on the cell cycle of human cancer cellsin vitro, ANTI-CANC D, 11(1), 2000, pp. 55-61
Authors:
Kim, HH
Ha, HJ
Kim, SO
Kim, SK
Yoo, SE
Hong, KW
Citation: Hh. Kim et al., KR 31372, a benzopyran derivative, inhibits oxidized LDL-stimulated proliferation and migration of vascular smooth muscle cells, FUN CL PHAR, 14(5), 2000, pp. 469-476
Authors:
Kim, HJ
Kim, SH
Kim, SO
Lee, DH
Lim, H
Yoo, SE
Lee, MG
Citation: Hj. Kim et al., Dose-dependent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378, in rats, BIOPHARM DR, 21(7), 2000, pp. 279-284
Authors:
Jang, IJ
Yu, KS
Shon, JH
Bae, KS
Cho, JY
Yi, SY
Shin, SG
Ryu, KH
Cho, YB
Kim, DK
Yoo, SE
Citation: Ij. Jang et al., Pharmacokinetic/pharmacodynamic evaluation of a novel potassium channel opener, SKP-450, in healthy volunteers, J CLIN PHAR, 40(7), 2000, pp. 752-761
Authors:
Yoo, SE
Gong, YD
Seo, JS
Sung, MM
Lee, SS
Kim, Y
Citation: Se. Yoo et al., X-ray photoelectron spectroscopy analysis of solid-phase reactions using 3-brominated Wang resin, J COMB CHEM, 1(3), 1999, pp. 177-180
Citation: Se. Yoo et al., A comparative molecular field analysis and molecular modelling studies on pyridylimidazole type of angiotensin II antagonists, BIO MED CH, 7(12), 1999, pp. 2971-2976
Citation: Se. Yoo et al., Theoretical study on the regioselectivity of tetrazolylimines with alkyl Grignard reagents, B KOR CHEM, 20(4), 1999, pp. 441-444
Authors:
Lee, SH
Jung, YS
Lee, BH
Yun, SI
Yoo, SE
Shin, HS
Citation: Sh. Lee et al., Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT(1)-receptor antagonist, J CARDIO PH, 33(3), 1999, pp. 367-374
Authors:
Lee, BH
Seo, HW
Kwon, KJ
Yoo, SE
Shin, HS
Citation: Bh. Lee et al., In vivo pharmacologic profile of SK-1080, an orally active nonpeptide AT(1)-receptor antagonist, J CARDIO PH, 33(3), 1999, pp. 375-382
Authors:
Lee, BH
Lee, SH
Jung, YS
Seo, HW
Yoo, SE
Shin, HS
Citation: Bh. Lee et al., Pharmacological characterization of KR-30988, a novel non-peptide AT(1) receptor antagonist, in rat, rabbit and dog, J PHARM PHA, 51(10), 1999, pp. 1191-1200
Authors:
Kim, HH
Yoo, SE
Lee, WS
Rhim, BY
Hong, KW
Citation: Hh. Kim et al., SKP-450 inhibits migration and DNA synthesis stimulated by oxidized low density lipoprotein in smooth muscle cells, EUR J PHARM, 383(3), 1999, pp. 373-379
Citation: Ey. Lee et al., Biochemical basis for a cholesterol-lowering activity of 2-[2 ''-(1 '',3 ''-dioxolane)]-2-methyl-4-(2 '-oxo-1 '-pyrrolidinyl)-6-nitro-2H-1-benzopyran(SKP-450), a novel antihypertensive agent, BIOCH PHARM, 57(5), 1999, pp. 579-582